The SARS-CoV-2 spike CHO-K1 cell line has been developed by the stable transfection of the SARS-CoV-2 spike protein plasmid. SARS-CoV-2 spike CHO-K1 cell line provides consistent levels of expression of the SARS-CoV-2 spike protein on the cell surface.
Delta, Kappa, and Lambda SARS-CoV-2 Pseudotyped Lentivirus Now Available.
With the demand for vaccine development, Creative Diagnostics has developed two ELISA kits for the qualitative detection of SARS-CoV-2 neutralizing antibodies in serum and plasma. Our competitive assay format measures neutralizing antibodies of the SARS-CoV-2 spike RBD and ACE2 interaction in human plasma and serum.